Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scilight-Peptide is a biotechnology company specializing in the development and large-scale manufacturing of high-quality peptide reagents and active pharmaceutical ingredients (APIs). The company focuses heavily on metabolic health, providing research-grade and potentially clinical-grade peptides such as Semaglutide, Tirzepatide, and Retatrutide. Beyond metabolic indications, Scilight-Peptide supports drug discovery efforts in oncology and neurodegeneration through custom peptide synthesis and chemical modification services. They operate as both a supplier for the research community and a contract manufacturer for biopharmaceutical partners globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scilight-Peptide.